News Picture: Antiviral Treatments Reduce Cancer Risk for HIV Patients

AHAVA
Anniversary Sale! Up to 25% OFF
AMOREPACIFIC CORPORATION
50% Off Select Filtration Systems
Alibris: Books, Music, & Movies

Latest HIV News

MONDAY, June 11, 2018 (HealthDay News) — Long-term antiviral treatment cuts the risk of cancer in HIV patients as they age, a new study says.

People with HIV are at increased risk for both AIDS-related cancers (Kaposi sarcoma, non-Hodgkin lymphoma or invasive cervical cancer) and non-AIDS-related cancers (lung and larynx cancer, melanoma and leukemia).

bareMinerals
Buy 2, Get 1 Free on Select Redken & Biolage Haircare at Beauty Brands. Shop Now.
728x90 banner
Bcbg Max Azria Group, LLC
Avéne USA

Antiretroviral therapy (ART) is a major part of HIV treatment, and previous research has shown a link between long-term viral suppression and reduced risk for certain types of cancer. However, no studies have specifically examined the effect of long-term viral suppression on overall cancer risk.

In this study, Stanford University researchers compared cancer rates between 1999 and 2015 among more than 42,000 HIV-positive veterans and more than 104,000 uninfected veterans.

Cancer risk was highest among HIV patients with no viral suppression, lower among those with early suppression, lower still among those with long-term suppression, and lowest in uninfected patients.

The findings are useful for infectious disease and internal medicine doctors caring for aging HIV patients, according to the researchers.

Mother’s Day Special: Take 12% Extra OFF Everything + Free Shipping Worldwide. Use Coupon: MDSALE12
Free Shipping & 7% Off at BudgetPetCare Labor's Day Sale. Use Coupon: BPCLDS7
boobydoo
Blink Health
Free US Shipping

The study was led by Lesley Park, an instructor in medicine, and published June 11 in the journal Annals of Internal Medicine.

— Robert Preidt

MedicalNews
Copyright © 2018 HealthDay. All rights reserved.

CONTINUE SCROLLING FOR NEXT NEWS ARTICLE

SOURCE: Annals of Internal Medicine, news release, June 11, 2018